C. Sánchez-Mora, M. Ribasés, J. Ramos-Quiroga, Miquel Casas, R. Bosch, A. Boreatti‐Hümmer, M. Heine, C. Jacob, K. Lesch, O. B. Fasmer, O. B. Fasmer, Per Knappskog, Per Knappskog, J. Kooij, Cornelis C. Kan, J. K. Buitelaar, E. Mick, P. Asherson, Steve Faraone, Barbara Franke, S. Johansson, S. Johansson, J. Haavik, J. Haavik, A. Reif, M. Bayés, B. Cormand, B. Cormand
2010.3.1AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
tlooto Summary
This study showed validation of some bivalent inactivated NDV and IB vaccines batches in vaccination programs and invalidation of other batches for use.
Abstract
using Haemagglutination inhibition test and ELISA test against IB virus. Challenge trial of tested vaccines showed variable percent of protection (50% to 100%). Virus shedding in SPF eggs on 3rd, 5 th , 7 th and 10 th days post challenge revealed significant amount of virus in oropharengeal swabs. This study showed validation of some bivalent inactivated NDV and IB vaccines batches in vaccination programs and invalidation of other batches for use.
Citation format
SÁNCHEZ-MORA, C., et al. Meta‐analysis of brain‐derived neurotrophic factor p.val66met in adult ADHD in four European populations. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B.